Loss of Rho GDIα and Resistance to Tamoxifen via Effects on Estrogen Receptor α

Phosphorylation of the mutant K303R estrogen receptor α at serine 305 affects aromatase inhibitor sensitivity

(2010) I Barone et al.   ONCOGENE

Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor α and its phosphorylation at serine 305

(2009) Cinzia Giordano et al.   BREAST CANCER RESEARCH AND TREATMENT

Expression of the K303R Estrogen Receptor-  Breast Cancer Mutation Induces Resistance to an Aromatase Inhibitor via Addiction to the PI3K/Akt Kinase Pathway

(2009) I. Barone et al.   CANCER RESEARCH

BRCA1 Regulates Acetylation and Ubiquitination of Estrogen Receptor-α

(2009) Yongxian Ma et al.   MOLECULAR ENDOCRINOLOGY

Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen

(2008) Marleen Kok et al.   BREAST CANCER RESEARCH AND TREATMENT

Identification of CDK10 as an Important Determinant of Resistance to Endocrine Therapy for Breast Cancer

(2008) Elizabeth Iorns et al.   CANCER CELL

A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast Cancer

(2008) M. Chanrion et al.   CLINICAL CANCER RESEARCH

Phosphorylation of the oestrogen receptor α at serine 305 and prediction of tamoxifen resistance in breast cancer

(2008) C Holm et al.   JOURNAL OF PATHOLOGY